Albaron Partners LP has sold Beyond Podiatry, a leading Midwest podiatric practice management company, to CUC Inc. for $87 million, marking a significant entry into the U.S. market for CUC.

Target Overview

On January 5, 2024, Albaron Partners LP announced the completion of the sale of Albaron Podiatry Holdings LLC, operating as Beyond Podiatry. As the leading podiatric medicine practice management company in the Midwest, Beyond Podiatry is dedicated to treating lower extremity conditions and serves over 250,000 patients annually. With a workforce of over 200 employees and a network of more than 30 locations across states like Michigan, Illinois, Ohio, Kentucky, and Indiana, Beyond Podiatry has seen consistent growth since its establishment in 2018, primarily driven by mergers and acquisitions as well as new clinic openings.

This strategic acquisition values Beyond Podiatry at $87 million, marking a significant milestone as it is the first acquisition by CUC Inc. in the United States, as well as the first private equity exit in the U.S. podiatry sector.

Industry Overview

The U.S. podiatry market has been experiencing steady growth, propelled by the increasing prevalence of foot and ankle disorders among the population. With rising awareness regarding podiatric health, patients are seeking specialized ca